Reditux 500 mg Injection
471,06$
142,41$
Reditux 500 mg Injection is a targeted monoclonal antibody therapy designed to address a range of disorders, particularly those affecting the immune system. Primarily utilized in the treatment of certain hematological malignancies, it is effective against non-Hodgkin's lymphoma and chronic lymphocytic leukemia, offering hope to patients battling these conditions. The mechanism of action involves binding to the CD20 protein found on the surface of B-cells, leading to their destruction and helping to restore normal immune function. While Reditux is generally well-tolerated, it is essential to be aware of potential side effects, including infusion reactions and infections, which necessitate close monitoring by healthcare professionals. Patients should also inform their doctor of any pre-existing conditions or medications to avoid possible interactions. As a vital component of cancer treatment regimens, Reditux offers a promising avenue for those seeking effective therapies for their illnesses. Always consult a healthcare provider for personalized medical advice and treatment options tailored to individual needs.
Cantidad
Active Pharmaceutical Ingredient
Uses
• Reditux 500 mg injection is primarily used in the treatment of non-Hodgkin lymphoma (NHL), a type of blood cancer that originates in the lymphatic system. This medication helps target and destroy cancerous B cells, thereby reducing tumor size and improving patient outcomes. Patients undergoing treatment with Reditux often experience a significant reduction in disease symptoms. This targeted approach allows for better management of the disease.
• In addition to its use in non-Hodgkin lymphoma, Reditux 500 mg injection is also indicated for chronic lymphocytic leukemia (CLL). CLL is a slow-growing cancer that affects the blood and bone marrow, leading to an accumulation of abnormal lymphocytes. The administration of Reditux helps to eliminate these malignant cells, thus helping to restore normal blood cell production. This treatment option can be crucial for managing the progression of CLL.
• Reditux 500 mg injection is utilized in the management of rheumatoid arthritis, particularly in patients who have not responded adequately to other therapies. This medication works by targeting specific B cells that contribute to the inflammatory process in rheumatoid arthritis. By reducing inflammation and joint damage, Reditux can improve mobility and overall quality of life for affected individuals. It is often part of a comprehensive treatment plan tailored to the patient's needs.
• Furthermore, Reditux 500 mg injection plays a role in treating conditions such as granulomatosis with polyangiitis and microscopic polyangiitis, both of which are forms of vasculitis. These conditions involve inflammation of blood vessels, leading to organ damage and various systemic symptoms. Reditux helps to modulate the immune response, reducing inflammation and preventing further complications. This makes it an important therapeutic option for patients suffering from these serious autoimmune conditions.
Benefits
Non-Hodgkin lymphoma (NHL): Non-Hodgkin's lymphoma is a form of cancer that affects the white blood cells in the body. These cells are responsible for preventing infections. Reditux 500 mg Injection has been demonstrated to reduce the immune response and relieve pain and inflammation. It also can kill cancer cells and prevent their further growth. To prevent the spread of infection, it is advisable to avoid crowds and to wash your hands frequently. It is recommended that patients consume an adequate quantity of fluids unless otherwise advised by their physician. Rheumatoid arthritis: Reditux 500 mg is an immunosuppressant that is used to treat rheumatoid arthritis. It is administered in a dose and frequency that is tailored to the patient's condition. This is determined by the physician. It is crucial to adhere to the physician's instructions and to promptly report any adverse effects, including fever, chills, or other symptoms, to the physician. Blood cancer (Chronic lymphocytic leukaemia): Leukaemia, also known as blood cancer, is a malignant neoplasm of the haematopoietic tissues that impairs the body's ability to combat infection. Reditux 500 Injection is a chemotherapeutic agent that kills or inhibits the proliferation of malignant cells and is effective in the treatment of leukaemia. However, it is important to discuss the potential side effects and benefits of this medication with a qualified healthcare professional. It is also essential to inform your doctor of any adverse effects that may arise during treatment. Granulomatosis with polyangiitis: Granulomatosis with polyangiitis (GPA) is a condition that causes inflammation of the blood vessels of the ears, nose, throat, lungs, and kidneys. In this condition, the blood flow to these areas may be reduced, which can lead to their damage. Reditux 500 mg Injection is an effective treatment that helps reduce inflammation, pain, and swelling and prevents further damage. This improves the quality of life of those affected by GPA. Microscopic polyangiitis: Microscopic polyangiitis is an autoimmune disease that affects the small blood vessels and may be caused by an imbalance in the immune system. Reditux 500 Injection reduces the immune response and improves inflammation. This helps to heal the condition and to alleviate discomfort.
Side Effects
Reditux 500 mg Injection can cause various adverse effects that can differ from one person to another. Some of the adverse effects of the drug are listed below.
Most Common Side Effects
• Low Immunity
• Nausea
• Tinnitus
• Muscle Pain and Stiffness
• Face Swelling
• Low Blood Count of White Blood Cells and Red Blood Cells
• Increase in Glucose Levels in Blood
• Headache
Common Side Effects
• Skin Reactions
• Heart Problems
• Infections
• Allergies
How To Use
The administration of Reditux 500 mg Injection is typically conducted by a medical professional, such as a doctor or nurse, in a medical facility, such as a hospital or clinic. It is not advisable to administer the product independently, and it is important to adhere to the instructions provided by a qualified healthcare professional.
Safety Advice
• Alcohol: Caution should be exercised when drinking alcohol with Reditux 500 mg. Please consult your doctor.
• Kidney: Reditux 500 Injection is likely to be safe in patients with kidney disease. The limited data available suggest that dose adjustment of Vortuxi Solution for Infusion may not be necessary for these patients. Please consult your doctor.
• Breastfeeding: Reditux 500 mg Injection is likely to be safe to use while breast-feeding, and limited human statistics support that the drug now no longer poses a good risk to the baby.
• Liver: Reditux 500 mg Injection is not recommended in patients with active liver disease or those who have had viral hepatitis. Please consult your doctor.
• Pregnancy: Reditux 500 mg Injection may not be safe for use during pregnancy. Although there is limited human research, animal research has shown dangerous effects on the growing baby. Your doctor will weigh up the benefits and potential risks before prescribing it to you. Please consult your doctor.
• Driving: It is not known whether Reditux 500 mg affects your ability to drive. Do not drive if you experience symptoms that affect your ability to concentrate and react.